共 50 条
- [1] NYVAC AND ALVAC VECTORS IN RETROVIRUS VACCINE DEVELOPMENTAIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S27 - S27TARTAGLIA, JCOX, WIPAOLETTI, E
- [2] Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trialLANCET HIV, 2019, 6 (11): : E737 - E749Pantaleo, GiuseppeJanes, HollyKaruna, ShellyGrant, ShannonOuedraogo, G. LaissaAllen, MaryTomaras, Georgia D.Frahm, NicoleMontefiori, David C.Ferrari, GuidoDing, SongLee, CarterRobb, Merlin L.Esteban, MarianoWagner, RalfBart, Pierre-AlexandreRettby, NilsMcElrath, M. JulianaGilbert, Peter B.Kublin, James G.Corey, Lawrence
- [3] Improved NYVAC-Based Vaccine VectorsPLOS ONE, 2011, 6 (11):Kibler, Karen V.Gomez, Carmen E.Perdiguero, BeatrizWong, ShukmeiTrung HuynhHolechek, SusanArndt, WilliamJimenez, VictoriaGonzalez-Sanz, RubenDenzler, KarenHaddad, Elias K.Wagner, RalfSekaly, Rafick P.Tartaglia, JamesPantaleo, GiuseppeJacobs, Bertram L.Esteban, Mariano
- [4] NYVAC AND ALVAC VECTORS IN RETROVIRUS VACCINE DEVELOPMENTJOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 680 - 680PAOLETTI, ECOX, WIJARRETT, OWEINHOLD, KTARTAGLIA, J
- [5] Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDSHUMAN VACCINES, 2009, 5 (12): : 867 - 871Esteban, Mariano
- [6] Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved AntigensJOURNAL OF VIROLOGY, 2016, 90 (08) : 4133 - 4149Asbach, BenediktKliche, AlexanderKoestler, JosefPerdiguero, BeatrizEsteban, MarianoJacobs, Bertram L.Montefiori, David C.LaBranche, Celia C.Yates, Nicole L.Tomaras, Georgia D.Ferrari, GuidoFoulds, Kathryn E.Roederer, MarioLanducci, GaryForthal, Donald N.Seaman, Michael S.Hawkins, NatalieSelf, Steven G.Sato, AliciaGottardo, RaphaelPhogat, SanjayTartaglia, JamesBarnett, Susan W.Burke, BrianCristillo, Anthony D.Weiss, Deborah E.Francis, JesseGalmin, LindseyDing, SongHeeney, Jonathan L.Pantaleo, GiuseppeWagner, Ralf
- [7] Functioning envelope protein intermediates as HIV vaccine targetsRETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2000, : 9 - 11Nunberg, JH
- [8] Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC VectorsPLOS ONE, 2011, 6 (02):Quakkelaar, Esther D.Redeker, AnkeHaddad, Elias K.Harari, AlexandreMcCaughey, Stella MayoDuhen, ThomasFilali-Mouhim, AbdelaliGoulet, Jean-PhilippeLoof, Nikki M.Ossendorp, FerryPerdiguero, BeatrizHeinen, PaulGomez, Carmen E.Kibler, Karen V.Koelle, David M.Sekaly, Rafick P.Sallusto, FedericaLanzavecchia, AntonioPantaleo, GiuseppeEsteban, MarianoTartaglia, JimJacobs, Bertram L.Melief, Cornelis J. M.
- [9] Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial (vol 6, pg e737, 2019)LANCET HIV, 2020, 7 (12): : E803 - E803Pantaleo, G.Janes, H.Karuna, S.
- [10] Comparison of the efficacy of replication defective adenovirus and Nyvac poxvirus as vaccine vectors in miceVACCINE, 1996, 14 (11) : 1083 - 1087Gonin, POualikene, WFournier, AEloit, M